As a former congressman and medical doctor, I would like to alert the public and policymakers to a report that recommends shutting down current regulatory policy – specifically the “Green List” – which grants preferential treatment to some “trusted” foreign firms that import active pharmaceutical ingredients (APIs) into the United States. The report details why that trust-based system is frighteningly obsolete.
The post Exclusive—Dr. Michael C. Burgess: We Need a New Playbook to Guard Against Counterfeit Drug Ingredients from China appeared first on Breitbart.
